J&J Wins FDA Approval for Ottava Robotic Surgery System
Johnson & Johnson has received FDA clearance for its Ottava robotic surgical system, marking the company's entry into the US soft-tissue robotic surgery market. The system has been approved for use in multiple general surgery procedures involving the upper abdomen. Ottava is designed with a more compact operating room footprint than competing systems currently on the market. With this launch, J&J positions itself as a direct competitor to Intuitive Surgical, which currently dominates the robotic surgery space.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.

Discussion (0)
Log in to join the discussion and vote.
Log in